The latest closing stock price for Enfusion as of November 20, 2024 is 9.89.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-501 today, roughly -1 times their original investment - a -20.67% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 10.45, which is 5.7% above the current share price.
The Enfusion 52-week low stock price is 7.52, which is 24% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.00.
An investor who bought $1,000 worth of Enfusion stock at the IPO in 2021 would have $-501 today, roughly -1 times their original investment - a -20.67% compound annual growth rate over 3 years.
The all-time high Enfusion stock closing price was 22.94 on November 12, 2021.
The Enfusion 52-week high stock price is 10.45, which is 5.7% above the current share price.
The Enfusion 52-week low stock price is 7.52, which is 24% below the current share price.
The average Enfusion stock price for the last 52 weeks is 9.00.